In this article, we have provided stringent evidence that microglia are target cells for NGF—both in vitro and ex vivo—and that the activity carried out by this neurotrophin might result neuroprotective and anti‐inflammatory in the context of Alzheimer's disease‐related insults. The gene discussed is NGF; the disease is Alzheimer disease.